SG11202102697XA - Galactose oral composition and use thereof - Google Patents
Galactose oral composition and use thereofInfo
- Publication number
- SG11202102697XA SG11202102697XA SG11202102697XA SG11202102697XA SG11202102697XA SG 11202102697X A SG11202102697X A SG 11202102697XA SG 11202102697X A SG11202102697X A SG 11202102697XA SG 11202102697X A SG11202102697X A SG 11202102697XA SG 11202102697X A SG11202102697X A SG 11202102697XA
- Authority
- SG
- Singapore
- Prior art keywords
- oral composition
- galactose oral
- galactose
- composition
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/08—Hepato-biliairy disorders other than hepatitis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Pathology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- General Preparation And Processing Of Foods (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2018/111079 WO2020077632A1 (en) | 2018-10-19 | 2018-10-19 | Galactose oral composition and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202102697XA true SG11202102697XA (en) | 2021-04-29 |
Family
ID=70284403
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202103490RA SG11202103490RA (en) | 2018-10-19 | 2018-10-19 | Galactose oral composition and use thereof |
SG11202102697XA SG11202102697XA (en) | 2018-10-19 | 2018-10-19 | Galactose oral composition and use thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202103490RA SG11202103490RA (en) | 2018-10-19 | 2018-10-19 | Galactose oral composition and use thereof |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP3866762A4 (en) |
JP (1) | JP2022505270A (en) |
KR (1) | KR20210102188A (en) |
AU (2) | AU2018445495A1 (en) |
BR (1) | BR112021007021A2 (en) |
CA (1) | CA3115851A1 (en) |
EA (1) | EA202190761A1 (en) |
PH (2) | PH12021550610A1 (en) |
SG (2) | SG11202103490RA (en) |
WO (1) | WO2020077632A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6544954B1 (en) * | 2002-02-19 | 2003-04-08 | Oliver Yoa-Pu Hu | Stable galactose injection solutions |
US20040087514A1 (en) | 2002-09-06 | 2004-05-06 | Hughes Thomas E | Nutritional compositions |
WO2006060936A1 (en) * | 2004-12-10 | 2006-06-15 | Jacov Biotech Co. | The method of blood sample for liver function test and the sample paper |
EA026922B1 (en) * | 2011-04-20 | 2017-05-31 | Нэшнл Дифенс Эдьюкейшн Энд Рисерч Фаундейшн | Antituberculosis low side effect pharmaceutical composition containing antituberculosis drugs |
KR101743421B1 (en) * | 2015-10-16 | 2017-06-05 | 고려대학교 산학협력단 | Anticariogenic use of 3,6-anhydro-L-galactose |
-
2018
- 2018-10-19 SG SG11202103490RA patent/SG11202103490RA/en unknown
- 2018-10-19 AU AU2018445495A patent/AU2018445495A1/en not_active Abandoned
- 2018-10-19 BR BR112021007021-4A patent/BR112021007021A2/en unknown
- 2018-10-19 SG SG11202102697XA patent/SG11202102697XA/en unknown
- 2018-10-19 CA CA3115851A patent/CA3115851A1/en active Pending
- 2018-10-19 JP JP2021521235A patent/JP2022505270A/en active Pending
- 2018-10-19 KR KR1020217010827A patent/KR20210102188A/en not_active Application Discontinuation
- 2018-10-19 WO PCT/CN2018/111079 patent/WO2020077632A1/en active Application Filing
- 2018-10-19 EP EP18937427.5A patent/EP3866762A4/en active Pending
- 2018-10-19 EA EA202190761A patent/EA202190761A1/en unknown
-
2021
- 2021-03-17 PH PH12021550610A patent/PH12021550610A1/en unknown
- 2021-04-07 PH PH12021550776A patent/PH12021550776A1/en unknown
-
2023
- 2023-02-27 AU AU2023201158A patent/AU2023201158A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
SG11202103490RA (en) | 2021-05-28 |
EP3866762A4 (en) | 2022-06-01 |
JP2022505270A (en) | 2022-01-14 |
CA3115851A1 (en) | 2020-04-23 |
EA202190761A1 (en) | 2021-08-03 |
PH12021550610A1 (en) | 2021-10-04 |
EP3866762A1 (en) | 2021-08-25 |
AU2018445495A1 (en) | 2021-04-15 |
PH12021550776A1 (en) | 2021-12-13 |
KR20210102188A (en) | 2021-08-19 |
BR112021007021A2 (en) | 2021-07-13 |
WO2020077632A1 (en) | 2020-04-23 |
AU2023201158A1 (en) | 2023-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL279897A (en) | Fusosome compositions and uses thereof | |
SG11202011015QA (en) | Fusosome compositions and uses thereof | |
IL260718B (en) | Oral care compositions and methods of using the compositions | |
IL279755A (en) | Senolytic compositions and uses thereof | |
EP4074335A4 (en) | Immunostimulatory composition and use thereof | |
ZA202005143B (en) | Oral formulations and uses thereof | |
SG11202107687VA (en) | Prebiotic composition and its use | |
IL279877A (en) | Ivosidenib forms and pharmaceutical compositions | |
IL277663A (en) | Erenumab compositions and uses thereof | |
GB201807576D0 (en) | Compositions and uses thereof | |
IL285916A (en) | Novel compositions and use thereof | |
ZA202104261B (en) | Combination pharmaceutical compositions and methods thereof | |
GB201901413D0 (en) | Compositions and their use | |
GB201905509D0 (en) | Pharmaceutical compositions and associated lits and uses | |
SG11202102697XA (en) | Galactose oral composition and use thereof | |
GB201821138D0 (en) | Compositions and uses thereof | |
GB201812334D0 (en) | Compositions and uses thereof | |
GB201907591D0 (en) | Composition and use | |
GB201815215D0 (en) | Composition and use | |
IL257226A (en) | Inverse-freezing compositions and use thereof | |
GB202101543D0 (en) | Vaping e-liquid composition and the use thereof | |
IL282671A (en) | Therapeutic methods and compositions | |
GB201917989D0 (en) | Compositions and medical uses | |
GB201815546D0 (en) | Composition and uses thereof | |
GB201805096D0 (en) | Composition and uses thereof |